Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

Fact checked by Nick Blackmer Zepbound supports sustained weight loss for up to three years among adults with obesity and ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Patients regularly taking Eli Lilly & Co.’s obesity shot Zepbound tend to keep the weight off for at least three years, with ...

A study found that medicines marketed as Zepbound and Mounjaro can help people lose weight for up to three years.

Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

Ryan Rasmussen was determined to lose weight so he would be around to ski and spend time with his wife and children.

Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...